Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marni C Wiseman

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 15, 2005
Risk of second primary cancer and death following a diagnosis of nonmelanoma skin cancerZoann Nugent, Alain A Demers, Marni C Wiseman, et al.
Journal of the American Academy of Dermatology|July 16, 2005
Trends of nonmelanoma skin cancer from 1960 through 2000 in a Canadian populationAlain A Demers, Zoann Nugent, Catalin Mihalcioiu, et al.
Journal of the American Academy of Dermatology|April 28, 2009
Incidence and anatomic presentation of cutaneous malignant melanoma in central Canada during a 50-year period: 1956 to 2005Deepak K Pruthi, Regan Guilfoyle, Zoann Nugent, et al.
The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Medicale|May 14, 2009
Use of oral miltefosine for cutaneous leishmaniasis in Canadian soldiers returning from AfghanistanYoav Keynan, Oscar E Larios, Marni C Wiseman, et al.
Journal of Cutaneous Medicine and Surgery|July 13, 2012
Topical 5% imiquimod in the treatment of lentigo malignaJessica G Wong, Jack W P Toole, Alain A Demers, et al.
Journal of Cutaneous Medicine and Surgery|November 28, 2022
Proactive Topical Maintenance Treatment of Psoriasis: Subanalysis of Canadian Patients in the Phase III PSO-LONG TrialH Chih-Ho Hong, David N Adam, Jason K Rivers, et al.
Frontiers in Medicine|August 27, 2021
A Review of the Efficacy and Safety for Biologic Agents Targeting IL-23 in Treating Psoriasis With the Focus on TildrakizumabFeras M Ghazawi, Farhan Mahmood, Leon Kircik, et al.
Journal of Cutaneous Medicine and Surgery|March 24, 2022
Real-World Moderate-to-Severe Hidradenitis Suppurativa: Decrease in Disease Burden With AdalimumabWayne Gulliver, Afsaneh Alavi, Marni C Wiseman, et al.
Journal of Cutaneous Medicine and Surgery|November 22, 2017
Management of Moderate to Severe Plaque Psoriasis: The Emerging Role of IL-17 InhibitionRobert Bissonnette, Marc Bourcier, Melinda Gooderham, et al.
SAGE Open Medicine|December 17, 2021
Skin care and hygiene among healthcare professionals during and after the SARS-CoV-2 pandemicJason K Rivers, John P Arlette, Joel DeKoven, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 15, 2005
Risk of second primary cancer and death following a diagnosis of nonmelanoma skin cancerZoann Nugent, Alain A Demers, Marni C Wiseman, et al.
Journal of the American Academy of Dermatology|July 16, 2005
Trends of nonmelanoma skin cancer from 1960 through 2000 in a Canadian populationAlain A Demers, Zoann Nugent, Catalin Mihalcioiu, et al.
Journal of the American Academy of Dermatology|April 28, 2009
Incidence and anatomic presentation of cutaneous malignant melanoma in central Canada during a 50-year period: 1956 to 2005Deepak K Pruthi, Regan Guilfoyle, Zoann Nugent, et al.
The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Medicale|May 14, 2009
Use of oral miltefosine for cutaneous leishmaniasis in Canadian soldiers returning from AfghanistanYoav Keynan, Oscar E Larios, Marni C Wiseman, et al.
Journal of Cutaneous Medicine and Surgery|July 13, 2012
Topical 5% imiquimod in the treatment of lentigo malignaJessica G Wong, Jack W P Toole, Alain A Demers, et al.
Journal of Cutaneous Medicine and Surgery|November 28, 2022
Proactive Topical Maintenance Treatment of Psoriasis: Subanalysis of Canadian Patients in the Phase III PSO-LONG TrialH Chih-Ho Hong, David N Adam, Jason K Rivers, et al.
Frontiers in Medicine|August 27, 2021
A Review of the Efficacy and Safety for Biologic Agents Targeting IL-23 in Treating Psoriasis With the Focus on TildrakizumabFeras M Ghazawi, Farhan Mahmood, Leon Kircik, et al.
Journal of Cutaneous Medicine and Surgery|March 24, 2022
Real-World Moderate-to-Severe Hidradenitis Suppurativa: Decrease in Disease Burden With AdalimumabWayne Gulliver, Afsaneh Alavi, Marni C Wiseman, et al.
Journal of Cutaneous Medicine and Surgery|November 22, 2017
Management of Moderate to Severe Plaque Psoriasis: The Emerging Role of IL-17 InhibitionRobert Bissonnette, Marc Bourcier, Melinda Gooderham, et al.
SAGE Open Medicine|December 17, 2021
Skin care and hygiene among healthcare professionals during and after the SARS-CoV-2 pandemicJason K Rivers, John P Arlette, Joel DeKoven, et al.
Pageof 3